Form 4: ClearPoint Neuro CFO Danilo D'Alessandro Reports Acquisition of Restricted Stock Units
SEC Form 4 Filing
ClearPoint Neuro's CFO, Danilo D'Alessandro, reports the acquisition of 51,660 restricted stock units (RSUs) that vest over a three-year period.
Summary
- Danilo D'Alessandro, CFO of ClearPoint Neuro, Inc., filed a Form 4 on March 4, 2025, reporting a transaction that occurred on March 3, 2025.
- The transaction involved the acquisition of 51,660 Restricted Stock Units (RSUs).
- These RSUs represent a contingent right to receive one share of ClearPoint Neuro common stock per unit.
- The RSUs vest in three tranches: 20% on March 3, 2026, 40% on March 3, 2027, and 40% on March 3, 2028.
- D'Alessandro also has a Power of Attorney on file, allowing certain individuals to act on his behalf for Section 16 reporting requirements.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. It's a routine filing, but insider ownership is generally viewed favorably.
Positives
- The acquisition of RSUs by the CFO could be seen as a positive sign, indicating confidence in the company's future performance.
Future Outlook
The document does not contain specific forward-looking statements regarding the company's performance, but the vesting schedule of the RSUs suggests a multi-year commitment from the CFO.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates the CFO's acquisition of company stock, which is common practice for executive compensation.
Comparison to Industry Standards
- Executive compensation packages often include stock options or restricted stock units to align management's interests with those of shareholders.
- The vesting schedule of the RSUs is typical, designed to incentivize long-term performance and retention.
- Comparing the size of the RSU grant to those of peer companies' executives would provide further context on the magnitude of this award.
Stakeholder Impact
- The acquisition of RSUs by the CFO could positively influence shareholder sentiment, as it aligns the CFO's interests with those of the shareholders.
Key Dates
| Date | Description |
|---|---|
| 1/8/2025 | Date of execution of the Power of Attorney. |
| 03/03/2025 | Date of the transaction: acquisition of Restricted Stock Units. |
| 03/04/2025 | Date of Form 4 filing. |
| March 3, 2026 | 20% of the total shares vest. |
| March 3, 2027 | 40% of the total shares vest. |
| March 3, 2028 | 40% of the total shares vest. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.